Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients

Published:2020-09-07 Issue:11 Volume:50 Page:1222-1233
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Nagaoki Yuko¹²,Imamura Michio¹²,Teraoka Yuji¹²,Morio Kei¹²,Fujino Hatsue¹²,Ono Atsushi¹²,Nakahara Takashi¹²,Murakami Eisuke¹²,Yamauchi Masami¹²,Kawaoka Tomokazu¹²^ORCID,Miki Daiki¹²,Tsuge Masataka²³,Hiramatsu Akira¹²,Hayes C. Nelson¹²,Chayama Kazuaki¹²⁴^ORCID,Aikata Hiroshi¹²^ORCID

Affiliation:

1. Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science Hiroshima University Hiroshima Japan

2. Research Center for Hepatology and Gastroenterology Hiroshima University Hiroshima Japan

3. Natural Science Center for Basic Research and Development Hiroshima University Hiroshima Japan

4. RIKEN Center for Integrative Medical Sciences Yokohama Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13554

Reference37 articles.

1. Prognosis of chronic hepatitis c: Results of a large, prospective cohort study

2. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

3. Antiviral Therapy Decreases Hepatic Venous Pressure Gradient in Patients with Chronic Hepatitis C and Advanced Fibrosis

4. Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

5. Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapy;Liver International;2024-09-02

2. Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals;Livers;2024-07-30

3. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis;Hepatology International;2024-07-05

4. ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis;Journal of Gastroenterology;2024-05-10

5. mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response;Journal of Gastroenterology and Hepatology;2024-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3